Co-founded by Dr. Geoffrey Ling after experiences in Afghanistan and Iraq, Rockville-based On Demand Pharmaceuticals develops distributed systems for producing medicines at or near the point of care. Its Pharmacy on Demand™ platform supports agile 503A and 503B production, including sterile injectables, to help hospitals respond to drug shortages and reduce dependence on fragile global supply chains. A 2024 pilot with North Mississippi Health Services produced approximately 12,000 prefilled syringes without a quality failure or adverse patient event.
503A
compliance_program
503B
compliance_program
cGMP
compliance_program
USP 797
compliance_program
PGRrxPGRrx is a 503B pharmaceutical outsourcing facility that produces sterile and non-sterile compounded medicines to help healthcare providers navigate drug shortages and tailor dosage forms to patient needs. Founded by pharmacist Amit Gupta, the company also supports CMC and clinical-trial research, drawing on his experience leading sterile and non-sterile compounding in inpatient institutions. Its work is organized around supplying safe, personalized pharmaceutical access to communities facing gaps in availability.EXTON, PA
The Vanguard Utility CorporationBased in Apex, North Carolina, The Vanguard Utility develops and manufactures sterile liquid and injectable medicines aimed at easing persistent drug shortages. Its planned U.S. facility uses automated Blow-Fill-Seal technology to form, fill, and seal medicines in one sterile process, while its Global Pharmacy Reserve and Pharmaceutical Reserve Network extend access through unit-dose supply and partnerships with manufacturers. The company is an operational subsidiary of Apiject focused on rebuilding domestic capacity for essential medicines.NEWTOWN, PA
ProRx PharmaProRx Pharma is an Exton, Pennsylvania, FDA-registered 503B outsourcing facility that compounds sterile and non-sterile preparations for healthcare providers, with a particular focus on preventative care and medications affected by shortages. Its 6,888-square-foot pharmaceutical and manufacturing facility uses ISO-classified cleanrooms, automation and robotics, while the company’s pharmaceutical and healthcare team brings more than 70 years of cumulative industry experience. ProRx also holds a DEA Controlled Substance Registration Certificate and supports providers with independently tested preparations and extended Beyond-Use Dates.EXTON, PA
STAQ PharmaCreated to address higher standards in pharmaceutical compounding, STAQ Pharma operates FDA-registered 503B outsourcing facilities that produce sterile compounded medications for hospitals and healthcare systems. Its facilities were built from the ground up to cGMP standards, with the original Denver site opening in 2018 and a much larger Columbus facility producing its first commercial batch in 2023. Backed and guided by healthcare systems, STAQ supplies medications nationwide while focusing on drug-shortage resilience and consistent quality.